UNSPSC 51314355: Citric/dextromethorphan/ipecac/potassium/promethazine/sodium citrate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE302. This VA Drug Class (RE302) classifies this compound as belonging to the group NON-OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51314355 Citric/dextromethorphan/ipecac/potassium/promethazine/sodium citrate is a Commodity code under which state and local governments procure pharmaceutical products, including naloxone and other medications, through both standalone county health purchases and cooperative purchasing vehicles serving multi-state government coalitions. Recent solicitations show state and local buyers acquiring naloxone for community health programs, generic multi-source pharmaceuticals for distribution across government facilities, and evaluating direct-to-manufacturer prescription fulfillment models. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas), and cooperative purchasing alliances serving multiple states and localities (Minnesota Multistate Cooperative Purchasing Alliance). These procurements emphasize compliance with Drug Supply Chain Security Act requirements, cGMP certification, E-Verify authorization, and specific insurance coverages including commercial general liability and professional liability.

Recent activity spans Florida, Texas, and Minnesota-administered multi-state cooperatives. The Seminole County, Florida IFB (IFB60459723LAS), posted June 30, 2026, with response due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, on a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission issued a Request for Information (HHS0017013) on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802) on January 20, 2026, due March 26, 2026, for generic multi-source pharmaceuticals and OTC products for distribution through three authorized wholesalers, with awards effective July 1, 2026, and pricing weighted at 75 percent of evaluation criteria. None of the recent opportunities carry explicit set-aside designations for disadvantaged enterprises.